Long-Term Study of TS-142 in Patients with Insomnia

NCT05461352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients with Insomnia

Interventions

DRUG: TS-142 5 mg
DRUG: TS-142 10 mg

Sponsor

Taisho Pharmaceutical Co., Ltd.